Guard Therapeutics International AB Stock
Equities
GUARD
SE0021181559
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30 SEK | 0.00% | +0.67% | -16.20% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 302M 27.91M |
---|---|---|---|---|---|
Net income 2024 * | -99M -9.15M | Net income 2025 * | -99M -9.15M | EV / Sales 2024 * | - |
Net cash position 2024 * | 70M 6.47M | Net cash position 2025 * | 46M 4.25M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.05
x | P/E ratio 2025 * |
-3.05
x | Employees | 11 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.37% |
1 week | +0.67% | ||
Current month | +2.74% | ||
1 month | +62.16% | ||
3 months | +32.74% | ||
6 months | -8.81% | ||
Current year | -16.20% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 18-11-30 | |
Karin Botha
DFI | Director of Finance/CFO | 51 | 20-09-13 |
Michael Reusch
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
CHM | Chairman | 68 | 21-04-30 |
Göran Forsberg
BRD | Director/Board Member | 61 | 19-05-28 |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 22-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 30 | 0.00% | 7,695 |
24-05-02 | 30 | +2.74% | 5,167 |
24-04-30 | 29.2 | -1.35% | 1,222 |
24-04-29 | 29.6 | -0.67% | 1,794 |
24-04-26 | 29.8 | 0.00% | 9,584 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 11:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.20% | 27.94M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- GUARD Stock